| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Infinity Pharmaceuticals Inc
Infinity Pharmaceuticals Inc
NASDAQ:INFI
Infinity Pharmaceuticals Inc
Other Liabilities
Infinity Pharmaceuticals Inc
Other Liabilities Peer Comparison
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Infinity Pharmaceuticals Inc
NASDAQ:INFI
|
Other Liabilities
$46.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
21%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Liabilities
$32.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Liabilities
$3.4B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
24%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Liabilities
$6.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
0%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Liabilities
$1.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
51%
|
CAGR 10-Years
33%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Liabilities
$1.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
18%
|
See Also
What is Infinity Pharmaceuticals Inc's Other Liabilities?
Other Liabilities
46.6m
USD
Based on the financial report for Jun 30, 2023, Infinity Pharmaceuticals Inc's Other Liabilities amounts to 46.6m USD.
What is Infinity Pharmaceuticals Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
21%
Over the last year, the Other Liabilities growth was -4%. The average annual Other Liabilities growth rates for Infinity Pharmaceuticals Inc have been -3% over the past three years , and 21% over the past ten years .
You don't have any saved screeners yet
